SCHEDULE: Park Ha Biological Technology Stakeholder Update

Motovance Holdings Limited and Li Wang report a combined 9.7% beneficial ownership of Park Ha Biological Technology's Class A Ordinary Shares following warrant exercise.

Summary

• Motovance Holdings Limited and Li Wang have jointly filed a Schedule 13G, reporting their beneficial ownership of Park Ha Biological Technology Co., Ltd. Class A Ordinary Shares.
• The filing indicates a combined beneficial ownership of 422,500 shares, representing 9.7% of the outstanding Class A Ordinary Shares.
• This ownership level is based on the share count after a reverse stock split effective August 6, 2026, and includes shares issued upon the exercise of a warrant.
• Both Motovance Holdings Limited and Li Wang are identified as reporting persons, with Li Wang serving as Director for Motovance Holdings Limited.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new financial or strategic information.

Positives

• Increased transparency regarding significant shareholding in Park Ha Biological Technology.
• The filing clarifies ownership structure following a warrant exercise and reverse stock split.

Negatives

• No new financial performance data or strategic initiatives are disclosed in this filing.
• The filing does not provide details on the specific terms or cost of the warrant exercise.

Risks

• Potential for future share price volatility if the ownership stake is part of a larger strategic move not yet disclosed.
• The reliance on a Form 6-K for share count data introduces a dependency on that document's accuracy and completeness.

Future Outlook

This filing does not contain forward-looking statements or specific future guidance from the company. It solely reports on beneficial ownership.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders to report stakes exceeding 5% in a public company. This filing indicates a notable, though not controlling, ownership position in Park Ha Biological Technology.

Stakeholder Impact

• Shareholders: Increased awareness of a significant beneficial owner, potentially influencing market perception and future corporate actions.
• Management of Park Ha Biological Technology: May need to engage with or consider the interests of this significant shareholder group.

Next Steps

• Continued monitoring of Park Ha Biological Technology's filings for any further disclosures from Motovance Holdings Limited or Li Wang.
• Observation of any strategic actions taken by the reporting persons concerning their stake in the company.

Key Dates

Keywords

Beneficial Ownership, Schedule 13G, Park Ha Biological Technology, Motovance Holdings, Li Wang, Class A Ordinary Shares, Warrant Exercise, Reverse Stock Split